KMTS (KMTS) Earnings Call Analysis

18/25

Growth 5 Margin 4 Expansion 4 Platform 3 Financial 2

latest quarter score

Earnings Reports

18
Kestra Medical Technologies (KMTS) Q1 2027: 60% Revenue Growth Drives Gross Margin Expansion to 56.5%
September 15, 2026
18
Kestra Medical Technologies (KMTS) Q4 2026: Gross Margin Expands 1,100bps, Accelerating Market Penetration
July 15, 2026
20
Kestra (KMTS) Q3 2026: Gross Margin Expands 900bps as Territory Buildout Drives 63% Growth
March 18, 2026
17
Kestra (KMTS) Q2 2026: Gross Margin Surges to 50.6% as Clinical Evidence Drives Market Expansion
December 12, 2025
17
Kestra Medical (KMTS) Q1 2026: In-Network Patient Mix Climbs to 80%, Powering Margin Expansion
September 11, 2025
15
Kestra Medical Technologies (KMTS) Q4 2025: 71% Revenue Surge Highlights Market Expansion and Margin Leverage
July 15, 2025
18
Kestra Medical Technologies (KMTS) Q3 2025: Prescription Growth Drives 82% Revenue Surge Amid IPO-Fueled Expansion
April 14, 2025

Browse all companies